Stanford researchers identified a two-step immune process causing rare myocarditis after mRNA COVID-19 vaccines, primarily in ...

Discover how AI is revolutionizing RNA drug development in a new article published in Engineering. Learn about the potential ...

Researchers identify a shared RNA-protein interaction that could lead to broad-spectrum antiviral treatments for ...

The innovations of this year spanned a range of fields, including biotechnology, medicine, energy, environment, and chemistry ...

KOFST has been selecting and announcing the 'Top 10 Science and Technology News' annually since 2005 to raise public interest ...

Stanford scientists have uncovered how mRNA COVID-19 vaccines can very rarely trigger heart inflammation in young men — and ...

A new study finds that at least one Archaea has surprisingly flexibility when interpreting genetic code, which goes against a ...

Exosome therapy is one of the most talked-about regenerative treatments today, but it sits firmly in the experimental zone ...

A Stanford-led study probes why a very small number of people develop heart inflammation shortly after mRNA COVID-19 ...

News » DiNAQOR and Academic Partners Launch Paradigm Shift in In Vivo Delivery of Advanced Therapies DiNAQOR and Academic Partners Launch Paradigm Shift in In Vivo Delivery of Advanced Therapies ...

Studienergebnisse DiNAQOR and Academic Partners Launch Paradigm Shift in In Vivo Delivery of Advanced Therapies 23.12.2025 / 14:36 CET/CEST ...

A new research paper was published in Volume 17, Issue 11 of Aging-US on November 25, 2025, titled “A natural language ...